Clinical Trials Browser

Active not recruiting × Rectal Neoplasms × trifluridine tipiracil drug combination × Clear all

NCT04104139 2025-10-27

TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer

Phase 1 Active not recruiting

Gastrointestinal

Rectal Neoplasms

NCT03992456 2024-05-21

Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer

Phase 2 Active not recruiting

12 enrolled 16 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms